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the patient developed neurologic symptoms, par‑
ticularly in the range of cortical activities: dete‑
rioration in verbal contact, memory impairment, 
and disorientation followed by coma. Brain mag‑
netic resonance imaging suggested meningitis 
(Figure 1C and 1D). Cerebrospinal fluid analysis re‑
vealed high protein levels (283 mg/dl; reference 
range, 20–40 mg/dl), pleocytosis (white blood 
cell count, 70/µl), and high EBV load (6.2 × 103 
copies/ml). Subsequently, immunosuppression 
was modified: dexamethasone was introduced 
(8 mg 3 times daily) with complete CsA with‑
drawal. Due to the severity of the neurologic sta‑
tus, antiviral acyclovir was switched to foscar‑
net, and 3 doses of IV etoposide (100 mg) as well 
as 2 doses of intrathecal methotrexate (15 mg) 
were administered, in parallel with weekly ritux‑
imab (up to 5 infusions). The patient’s general 
condition improved. Finally, the EBV clearance 
was achieved. A dose of systemic dexamethasone 
was gradually tapered, simultaneously with re‑
starting CsA. At present, 5 years after the trans‑
plant, the patient is alive and remains in com‑
plete remission.
The EBV is a highly immunogenic γ ‑herpesvirus. 
Severely immunosuppressed patients devel‑
op B ‑cell proliferation and a diminished EBV‑
‑specific cytotoxic T ‑cell population.3 B ‑cell PTLD 
associated with EBV is a life ‑threatening com‑
plication after allo ‑HSCT, resulting from an out‑
growth of infected donor ‑origin B cells.3 In pa‑
tients after allo ‑HSCT, EBV is the second most 
common cause of viral encephalitis, after human 
A 28 ‑year ‑old man with Ph ‑negative acute lym‑
phoblastic leukemia was readmitted to the Bone 
Marrow Transplant Unit on day 42 after matched 
unrelated donor allogeneic hematopoietic stem 
cell transplantation (allo ‑HSCT), presenting with 
fever, general malaise, tonsillitis, lymphadenop‑
athy, and splenomegaly. The pretransplant pa‑
tient / donor cytomegalovirus (CMV) status was 
positive / negative, and the Epstein–Barr virus 
(EBV) status was positive / positive. On admis‑
sion, a high blood EBV load (1.2 × 105 copies/ml) 
was detected. Due to progressing organomega‑
ly and elevation of lactate dehydrogenase lev‑
els after standard treatment with rituximab 
(375 mg/m2 intravenously [IV]), 18F ‑fluorode‑
oxyglucose positron emission tomography–com‑
puted tomography was performed. It revealed 
abnormally increased metabolic activity in multi‑
ple enlarged lymph nodes and the spleen (Figure 1A 
and 1B). Because of pancytopenia progression, ad‑
ditional blood tests were performed. Prominent 
hyperferritinemia (ferritin levels, 74 000 µg/l; 
reference range, 13–400 µg/l) with hypertri‑
glyceridemia (triglyceride levels, 3.73 mmol/l; 
reference range, <2.26 mmol/l) were noted. Pe‑
ripheral blood lymphocyte immunophenotyp‑
ing showed a sparse natural killer (NK) cell pop‑
ulation. A tentative diagnosis of posttransplant 
lymphoproliferative disorder (PTLD), accom‑
panied by hemophagocytic lymphohistiocyto‑
sis (HLH), was made.1,2 Despite the adminis‑
tration of the second and third rituximab dose 
and a reduction of cyclosporine A (CsA) dosage, 
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central nervous system involvement. In our case, 
focusing on HLH as a major life ‑threatening 
event, the adoption of HLH ‑2004 therapeutic 
modalities provided an excellent clinical out‑
come in a rituximab ‑refractory disease. How‑
ever, the negative pretransplant EBV immuni‑
ty status in a donor and coreactivation of virus‑
es may impede treatment.
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herpesvirus 6.4 Hemophagocytic lymphohistio‑
cytosis, characterized by molecular abnormali‑
ties and clinical or laboratory findings such as 
fever, splenomegaly, cytopenia, reduced NK cell 
activity, hypofibrinogenemia, hemophagocyto‑
sis, and increased levels of soluble CD25 pro‑
tein, ferritin, and triglycerides, has become more 
widely recognized in adults, predominately as 
a secondary disease.5 The treatment strategy in 
EBV ‑driven HLH depends on the patient’s con‑
dition, from short ‑term corticosteroids with or 
without immunoglobulins in less severe disease 
to intensive treatment with early etoposide ad‑
ministration in rapidly deteriorating patients.5 
There is no established standard of care in pa‑
tients fulfilling the HLH ‑2004 diagnostic cri‑
teria for HLH after allo ‑HSCT. In our patient, 
based on the high EBV load and imaging, prob‑
able PTLD was diagnosed, complicated by HLH. 
The differential diagnosis should include EBV 
meningoencephalitis and advanced HLH with 
Figure 1  A – 18F ‑fluoro deoxy glucose positron emission tomography–computed tomography (18F ‑FDG PET/CT; 
coronal view): a maximal intensity projection scan showing an increased 18F ‑FDG uptake in the lymph nodes and spleen; 
B – 18F ‑FDG PET/CT (coronal view): a fusion scan showing a diffuse 18F ‑FDG uptake of the lymphoid tissue—the highest 
in the para ‑aortic, liver hilar, and pancreatic lymph node groups (maximum standardized uptake value [SUVmax],18.8) 
and left ‑side neck lymph nodes (SUVmax, 16.6), while medium in the spleen (SUVmax, 10.7) and peripheral lymph 
nodes (SUVmax, 3.1–9.8); C – brain magnetic resonance imaging (MRI): a T1 ‑weighted sequence showing global 
meningeal thickening (arrow); D – brain MRI: a T1 ‑weighted sequence showing postcontrast meningeal enhancement 
(arrow)
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